Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Nzokirantevye A"'
Autor:
Arthur, Amani *, Orton, Matthew R *, Emsley, Robby, Vit, Sharon, Kelly-Morland, Christian, Strauss, Dirk, Lunn, Jason, Doran, Simon, Lmalem, Hafida, Nzokirantevye, Axelle, Litiere, Saskia, Bonvalot, Sylvie, Haas, Rick, Gronchi, Alessandro, Van Gestel, Dirk, Ducassou, Anne, Raut, Chandrajit P, Meeus, Pierre, Spalek, Mateusz, Hatton, Matthew, Le Pechoux, Cecile, Thway, Khin, Fisher, Cyril, Jones, Robin, Huang, Paul H †, Messiou, Christina †, *
Publikováno v:
In The Lancet Oncology November 2023 24(11):1277-1286
Autor:
Schöffski, Patrick, Sufliarsky, Jozef, Gelderblom, Hans, Blay, Jean-Yves, Strauss, Sandra J, Stacchiotti, Silvia, Rutkowski, Piotr, Lindner, Lars H, Leahy, Michael G, Italiano, Antoine, Isambert, Nicolas, Debiec-Rychter, Maria, Sciot, Raf, Van Cann, Thomas, Marréaud, Sandrine, Nzokirantevye, Axelle, Collette, Sandra, Wozniak, Agnieszka
Publikováno v:
In The Lancet Respiratory Medicine June 2018 6(6):431-441
Autor:
Schöffski, Patrick, Wozniak, Agnieszka, Leahy, Michael G., Aamdal, Steinar, Rutkowski, Piotr, Bauer, Sebastian, Richter, Stephan, Grünwald, Viktor, Debiec-Rychter, Maria, Sciot, Raf, Geoerger, Birgit, Marréaud, Sandrine, Collette, Sandra, Nzokirantevye, Axelle, Strauss, Sandra J.
Publikováno v:
In European Journal of Cancer May 2018 94:156-167
Autor:
Wiemer, Erik A.C., Wozniak, Agnieszka, Burger, Herman, Smid, Marcel, Floris, Giuseppe, Nzokirantevye, Axelle, Sciot, Raf, Sleijfer, Stefan, Schöffski, Patrick
Publikováno v:
In European Journal of Cancer April 2017 75:33-40
Autor:
Anastasios Kyriazoglou, Pieter Jespers, Vincent Vandecavaye, Olivier Mir, Bernd Kasper, Zsuzsanna Papai, Jean-Yves Blay, Antoine Italiano, Facundo Zaffaroni, Saskia Litière, Axelle Nzokirantevye, Patrick Schöffski
Publikováno v:
Acta Oncologica. 61:663-668
Gastrointestinal stromal tumors (GISTs) are malignant mesenchymal tumors arising in the gastrointestinal tract. Their systemic treatment is based on the use of tyrosine kinase inhibitors (TKIs) with imatinib, sunitinib, and regorafenib being the pref
Autor:
Licitra, L.F.L., Locati, L.D., Digue, L., Even, C., Psyrri, A., Clement, P.M., Ochsenreither, S., Delord, J-P., Moro, C., Machiels, J-P., Fuereder, T., Govaerts, A-S., Quattrone, P., De Cecco, L., Perrone, F., Rasschaert, M., Nzokirantevye, A., Joaquim, A., Venslovaite, E., Fortpied Lefevre, C.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S1227-S1228
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bernd Kasper, Palma Dileo, Zsuzsanna Papai, Axelle Nzokirantevye, Antoine Italiano, Charlotte Benson, Katerina Kopeckova, Saskia Litière, Isabelle Vanden Bempt, Facundo Zaffaroni, Eva Wardelmann, A. Lecesne, Olivier Mir, Nasim Ali, Agnieszka Wozniak, Patrick Schöffski, Franka Menge, Sandrine Marreaud, Sophie Cousin, Jean-Yves Blay, Hans Gelderblom
Publikováno v:
European Journal of Cancer, 134, 62-74. ELSEVIER SCI LTD
Background Gastrointestinal stromal tumour (GIST) is commonly treated with tyrosine kinase inhibitors (TKIs), but most patients ultimately develop secondary resistance. Cabozantinib, a multi-targeted TKI inhibitor, has activity in patient-derived GIS
Autor:
Che-Jui Lee, Michael G Leahy, Tomasz Switaj, Maria Debiec-Rychter, Sandra J. Strauss, Axelle Nzokirantevye, Anouk Neven, Bernd Kasper, Frank M. Speetjens, Antoine Italiano, Michaela Kubickova, Veit Bücklein, Raf Sciot, Agnieszka Wozniak, Jean-Yves Blay, Patrick Schöffski, Silvia Stacchiotti, Nicolas Isambert
Publikováno v:
European Journal of Cancer, 156, 12-23. ELSEVIER SCI LTD
Purpose: European Organisation for Research and Treatment of Cancer (EORTC) 90101 (CREATE) was a prospective, multicentric, non-randomised, open-label phase II bas-ket trial to assess the efficacy and safety of crizotinib in patients with different t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.